We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Quantification of Upper Extremity Hypertonia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00285870
First Posted: February 2, 2006
Last Update Posted: March 12, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Terence Sanger, University of Southern California
  Purpose
Dr. Sanger and the research team want to learn about upper extremity hypertonia (stiffness) in children and young adults with cerebral palsy. Specifically, they want to learn about ways to measure the stiffness in the joints of hypertonic arms. The information the research team will collect includes any physical exams or computer generated data about your arm movements.

Condition Phase
Dystonia Muscle Hypertonia Phase 1 Phase 2

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Quantification of Upper Extremity Hypertonia

Resource links provided by NLM:


Further study details as provided by Terence Sanger, University of Southern California:

Primary Outcome Measures:
  • Observation [ Time Frame: 1 hour ]

Enrollment: 60
Study Start Date: January 2006
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   4 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Children with cerebral palsy and/or dystonia.
Criteria

Inclusion Criteria:Dystonia in at least one arm Age 4 to no upper limit

Exclusion Criteria:increased risk of participation botulinum toxin within 6 months

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00285870


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
University of Southern California
Investigators
Principal Investigator: Terence D. Sanger Stanford University
  More Information

Responsible Party: Terence Sanger, Associate Professor, University of Southern California
ClinicalTrials.gov Identifier: NCT00285870     History of Changes
Other Study ID Numbers: UPPER EXTREMITY HYPERTONIA
First Submitted: January 31, 2006
First Posted: February 2, 2006
Last Update Posted: March 12, 2013
Last Verified: March 2013

Additional relevant MeSH terms:
Dystonia
Muscle Hypertonia
Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Neuromuscular Manifestations